Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia.
作者信息
Hung Anna, Growdon Matthew E
机构信息
Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
Duke-Margolis Institute for Health Policy, Durham, North Carolina, USA.
出版信息
J Am Geriatr Soc. 2025 Feb;73(2):343-346. doi: 10.1111/jgs.19294. Epub 2024 Nov 26.
Abstract
摘要
相似文献
1
Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia.痴呆患者中枢神经系统活性药物联合使用时的减药考量
J Am Geriatr Soc. 2025 Feb;73(2):343-346. doi: 10.1111/jgs.19294. Epub 2024 Nov 26.
2
Pharmacist-led telehealth deprescribing for people living with dementia and polypharmacy in primary care: A pilot study.药剂师主导的远程医疗减药用于初级保健中患有痴呆症和多种药物治疗的人群：一项试点研究。
J Am Geriatr Soc. 2024 Jul;72(7):1973-1984. doi: 10.1111/jgs.18867. Epub 2024 Mar 15.
3
Central Nervous System Polypharmacy Among People Living With Dementia.痴呆症患者的中枢神经系统多重用药情况
J Am Med Dir Assoc. 2025 Aug;26(8):105708. doi: 10.1016/j.jamda.2025.105708. Epub 2025 Jun 14.
4
Deprescribing tools and guidelines in chronic kidney disease: A scoping review.慢性肾脏病的减药工具与指南：一项范围综述
Res Social Adm Pharm. 2025 Sep;21(9):679-686. doi: 10.1016/j.sapharm.2025.05.005. Epub 2025 May 9.
5
An Educational Intervention to Promote Central Nervous System-Active Deprescribing in Dementia: A Pilot Study.一项促进痴呆症患者停用中枢神经系统活性药物的教育干预措施：一项试点研究。
Drugs Aging. 2025 Mar;42(3):257-265. doi: 10.1007/s40266-024-01178-x. Epub 2025 Jan 20.
6
A bitter pill to swallow - Polypharmacy and psychotropic treatment in people with advanced dementia.难以下咽的苦药——晚期痴呆患者的多种药物治疗和精神类药物治疗。
BMC Geriatr. 2022 Mar 16;22(1):214. doi: 10.1186/s12877-022-02914-x.
7
The value of deprescribing in older adults with dementia: a narrative review.老年痴呆症患者药物减量的价值：叙事性综述。
Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19.
8
Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis.临床药师在老年住院患者中的药物重整和药物精简的影响：系统评价和荟萃分析。
J Am Geriatr Soc. 2024 Oct;72(10):3219-3238. doi: 10.1111/jgs.19035. Epub 2024 Jun 1.
9
Management of polypharmacy through deprescribing in older patients: a review of the role of AI tools.老年患者通过减药管理多重用药：人工智能工具作用的综述
Expert Rev Clin Pharmacol. 2025 Jun;18(6):333-345. doi: 10.1080/17512433.2025.2519648. Epub 2025 Jun 13.
10
eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators.老年人减药的电子咨询：临床医生对实施障碍和促进因素的看法
J Gen Intern Med. 2024 Oct;39(13):2461-2470. doi: 10.1007/s11606-024-08899-0. Epub 2024 Jun 28.
本文引用的文献
1
Clinician contributions to central nervous system-active polypharmacy among older adults with dementia in the United States.美国临床医生对患有痴呆症的老年人使用中枢神经系统活性复方药物的影响。
J Am Geriatr Soc. 2025 Feb;73(2):422-430. doi: 10.1111/jgs.19256. Epub 2024 Nov 5.
2
eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators.老年人减药的电子咨询：临床医生对实施障碍和促进因素的看法
J Gen Intern Med. 2024 Oct;39(13):2461-2470. doi: 10.1007/s11606-024-08899-0. Epub 2024 Jun 28.
3
American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults.美国老年医学学会 2023 年更新了老年人潜在不适当药物使用的 AGS Beers 标准®。
J Am Geriatr Soc. 2023 Jul;71(7):2052-2081. doi: 10.1111/jgs.18372. Epub 2023 May 4.
4
Attitudes toward deprescribing among older adults with dementia in the United States.美国老年痴呆症患者对减药的态度。
J Am Geriatr Soc. 2022 Jun;70(6):1764-1773. doi: 10.1111/jgs.17730. Epub 2022 Mar 10.
5
Polypharmacy among older adults with dementia compared with those without dementia in the United States.美国痴呆老年患者与非痴呆老年患者的多药治疗比较。
J Am Geriatr Soc. 2021 Sep;69(9):2464-2475. doi: 10.1111/jgs.17291. Epub 2021 Jun 8.
6
Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.美国老年痴呆症患者中枢神经系统活性药物联合使用的流行率。
JAMA. 2021 Mar 9;325(10):952-961. doi: 10.1001/jama.2021.1195.
7
Prevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US.美国社区居住的老年痴呆症患者中精神类药物和阿片类药物处方的流行情况。
JAMA. 2020 Aug 18;324(7):706-708. doi: 10.1001/jama.2020.8519.
8
Barriers and facilitators to deprescribing in primary care: a systematic review.基层医疗中减药的障碍与促进因素：一项系统综述
BJGP Open. 2020 Aug 25;4(3). doi: 10.3399/bjgpopen20X101096. Print 2020 Aug.
9
Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population.北卡罗来纳州医疗补助计划人群中阿片类药物使用者与同时使用苯二氮䓬类药物者的风险因素和结局。
J Manag Care Spec Pharm. 2020 Feb;26(2):169-175. doi: 10.18553/jmcp.2020.26.2.169.
10
Association Between Medications Acting on the Central Nervous System and Fall-Related Injuries in Community-Dwelling Older Adults: A New User Cohort Study.中枢神经系统作用药物与社区居住老年人跌倒相关伤害的关系：一项新用户队列研究。
J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):1003-1009. doi: 10.1093/gerona/glz270.
Zotero 插件